Cited by 83Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychoanalysis and Psychopathology Research

Pharmacotherapy for obsessive‐compulsive disorder

Dougherty, Darin D., Rauch, Scott L., Jenike, Michael A.·2004·Journal of Clinical Psychology

Abstract

Pharmacotherapeutic options for obsessive-compulsive disorder (OCD) have expanded over the past half-century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first-line pharmacotherapy for OCD. High dosages and long trials of the SRIs are needed for adequate treatment of OCD. The use of SRIs for the treatment of OCD is reviewed, then other pharmacotherapeutic treatment options, including SRI augmentation and alternative monotherapies, are discussed. The preponderance of data demonstrates that SRI augmentation with neuroleptics is efficacious for treatment-refractory OCD. There is substantially less evidence supporting other alternative strategies. Finally, neurosurgical and device-based approaches for treatment-refractory OCD are reviewed.

Integrity signals

Registry

Crossref · 10.1002/jclp.20083

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dougherty, D. D., Rauch, S. L., & Jenike, M. A.
Affiliations
Harvard University (US)
Corresponding author
Dougherty, Darin D.
Venue
Journal of Clinical Psychology
Publisher
Wiley
Published
2004-09-10
Volume
60
Issue
11
Pages
1195-1202
ISSN
  • 0021-9762 (ISSN-L)
  • 1097-4679
OpenAlex
W2017491907
Cited by
83
References
3
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 4
FWCI
6.48
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
obsessive-compulsive disorder, pharmacotherapy, serotonin reuptake inhibitors, antipsychotic drugs, treatment-refractory OCD, neurosurgical treatment, deep brain stimulation, device therapy
MeSH terms
Clinical Trials as Topic, Desensitization, Psychologic, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Electric Stimulation Therapy, Humans, Magnetics, Obsessive-Compulsive Disorder, Psychosurgery, Antipsychotic Agents, Treatment Outcome, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review